Bimodal effect of glycyrrhizin on macrophage nitric oxide and prostaglandin E2 production

In Vivo

Volumn 22, Issue 5, 2008, Pages 583-586

  Kato, Takao ^a   Horie, Norio ^a,b   Hashimoto, Ken ^b   Satoh, Kazue ^b,d   Shimoyama, Tetsuo ^a   Kaneko, Tadayoshi ^b,c   Kusama, Kaoru ^b   Sakagami, Hiroshi ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d SHOWA UNIVERSITY   (Japan)

Author keywords

Chinese medicine; Glycyrrhizin; Macrophage; NO; PGE2

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; GLYCYRRHIZIC ACID; HYPOXANTHINE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROSTAGLANDIN E2; SUPEROXIDE; XANTHINE OXIDASE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENZYME MECHANISM; IC 50; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PROSTAGLANDIN SYNTHESIS;

EID: 53849136969     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Horie N, Satoh K, Hashimoto K, Shimoyama T, Kaneko T, Kusama K and Sakagami H: Inhibition by Rikko-san and its major ingredients of LPS-stimulated nitric oxide production by mouse macrophage-like cells. In Vivo 19: 165-172, 2005.
2. Tang B, Qiao H, Meng F and Sun X: Glycyrrhizin attenuates endotoxin-induced acute liver injury after partial hepatectomy in rats. Braz Med Biol Res 40: 1637-1646, 2007.
3. Rahman S and Sultana S: Glycyrrhizin exhibits potential chemopreventive activity on 12-O-tetradecanoylphorbol-13-acetate-induced cutaneous oxidative stress and tumor promotion in Swiss albino mice. J Enzyme Inhib Med Chem 22: 363-369, 2007.
4. Feng C, Wang H, Yao C, Zhang J and Tian Z: Diammonium glycyrrhizinate, a component of traditional Chinese medicine Gan-Cao, prevents murine T-cell-mediated fulminant hepatitis in IL-10- and IL-6-dependent manners. Int Immunopharmacol 7: 1292-1298, 2007.
5. Yang C, Liang GY, He ZY, Cao PX, Tian WY and Cai L: Determination of glycyrrhizic acid in different decoctions of sanaotang by HPLC and comparison with antifugal effects in vitro. Zhongguo Zhong Yao Za Zhi 32: 1031-1034, 2007 (In Chinese).
6. Miyamoto M, Sakagami H, Minagawa K, Kikuchi H, Nishikawa H, Satoh K, Komatsu N, Fujimaki M, Nakashima H, Gupta M, Sarma DNK and Mitra SK: Tumor-specificity and radical scavenging activity of poly-herbal formula. Anticancer Res 22: 1217-1224,2002.
7. Tashiro M, Suzuki F, Shirataki Y, Yokote Y, Akahane K, Motohashi N, Ishihara M, Jiang Y and Sakagami H: Effects of prenylflavanones from Sophora species on growth and activation of mouse macrophage-like cell line. Anticancer Res 22: 53-58, 2002.
8. Noda Y, Mori A and Packer L: Gliclazide scavenges hydroxyl, superoxide and nitric oxide radicals. An ESR study. Res Commun Mol Pathol Pharmacol 96: 115-124, 1997.
9. 2 production by mouse macrophage-like cells. In Vivo 20: 491-498, 2006.
10. Calabrere FJ: Paradigm lost, paradigm found: The re-emergence of hormesis as a fundamental dose-response model in the toxicological sciences. Environ Pollut 138: 379-412, 2005.
11. 2 levels. Biol Pharm Bull 21: 1277-1281, 1998.
12. 2 production by Rikko-san in activated macrophages. In Vivo 22: in press, 2008.
13. Kim SF, Huri DA and Snyder SH: Inducible nitric oxide synthase binds S-nitrosylates, and activates cyclooxygenase-2. Science 310: 1966-1970, 2005.
14. Atar S, Ye Y, Lin Y, Freeberg SY, Nishi SP, Rosanio S, Huang MH, Uretsky BF, Perez-Polo JR and Birnbaum Y: Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2. Am J Physiol Heart Circ Physiol 290: 1960-1968, 2006.